Considering that the SLC1A5 variant is an important regulator of the production of glutamine-derived α-KG16, confirming whether epigenetic regulation by glutamine-derived α-KG is affected by the SLC1A5 variant in cancer cells or stem cells is necessary (Fig. 5a). The gene discussed is SLC1A5; the disease is cancer.